In the light of bioinformatic prediction and experimental validation, this study presented extensive characterization of the anti-fibrotic role of KL in pulmonary fibrosis, rendering it a promising target of therapeutic intervention for patients with IPF. This evidence concerns the gene KL and pulmonary fibrosis.